Cai, Song-bai

Nanjing IASO Biotechnology Co., Ltd. (China)

1 paper on CoChat

Most cited papers

Verified
CT103A, a novel fully human BCMA-targeting CAR-T cells, in patients with relapsed/refractory multiple myeloma: Updated results of phase 1b/2 study (FUMANBA-1).
Li, C., Wang, D., Song, Y., Huang, H., Li, J., Chen, B., Liu, J., Dong, Y., Hu, K., Liu, P., et al. (2023) · Journal of Clinical Oncology
CAR-T cell therapy researchMultiple Myeloma Research and Treatments
Cited by 28

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free